CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DANIELS | — |
| MARY B DWIGHT | — |
Health Issues HCR
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DANIELS | — |
| MARY B DWIGHT | — |
Medicare/Medicaid MMM
H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DANIELS | — |
| MARY B DWIGHT | — |
Budget/Appropriations BUD
H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISION H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DANIELS | — |
| MARY B DWIGHT | — |
Insurance INS
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS,AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DANIELS | — |
| MARY B DWIGHT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.